News

Jiksak and Meiji Enter into a Joint Development Agreement

KAWASAKI, Japan - August 17, 2021 - Jiksak Bioengineering, Inc. (Jiksak) and Meiji Co., Ltd. (Meiji) today announced that they entered into a j

Jiksak’s Nerve Organoids™ Used to Discover New Modulatory Gene for ALS Pathogenesis

Joint research between Tohoku University and Keio University School of Medicine used Jiksak Bioengineering, Inc (Jiksak)’s Nerve Organoid™ chips and i

Jiksak and Sharp Display Technology Announce Jointly Developed Electrode Chip-embedded Nerve Organoid Device

KAWASAKI, Japan – March 30, 2021 – Jiksak Bioengineering, Inc. (Jiksak), a biotechnology company focused on finding a cure for amyotrophic lateral scl

Jiksak Partners with Cyberdyne for ALS Drug Discovery and Regenerative Medicine

Closes first round of Series B funding KAWASAKI, Japan – March 23, 2021 – Jiksak Bioengineering, Inc. (Jiksak), a biotechnology company focused on fi

Jiksak Interview with Serika Fund, a Japanese Association for Funding ALS Research (Japanese only)

Jiksak Selected as Participant for Yokohama Springboard Mentoring Program